Bone Healing and Fracture Biology

Bone heals via two pathways: primary (direct) healing requires absolute stability (less than 2% strain) with cutting cones crossing the fracture without callus, while secondary (indirect) healing follows four phases—Inflammation, Soft callus, Hard callus, Remodeling (ISHR)—through enchondral ossification forming visible callus. Perren's strain theory defines tissue tolerance: less than 2% = bone, 2-10% = cartilage intermediate (secondary healing), greater than 10% = fibrous tissue (nonunion risk). The Diamond Concept identifies four requirements: Cells (MSCs), Scaffold (osteoconductive matrix), Growth factors (BMPs for osteoinduction, VEGF for angiogenesis), and Mechanical environment. Key impairment factors: smoking doubles nonunion risk, diabetes, malnutrition, open fractures, infection, and poor fixation stability. Clinical union typically occurs at 6-12 weeks.

Bone healing is the complex biological process by which fractured bone regenerates and restores its original structure and function. Unlike most tissues which heal by scar formation, bone has the unique capacity for true regeneration without scar.

Why Bone Healing Biology Matters

Understanding fracture biology is essential for orthopaedic surgeons:

• Treatment selection: Choosing between absolute stability (plate) vs relative stability (IM nail) based on desired healing pathway
• Optimizing healing environment: Addressing patient factors (smoking cessation), ensuring adequate stability, considering biological augmentation
• Recognizing impaired healing: Early identification of delayed union or nonunion for timely intervention
• Using biologics appropriately: BMP use in high-risk cases (smoking, diabetes, revision surgery)

Epidemiology of Fracture Healing

• Most fractures heal: 90-95% of closed fractures achieve union with appropriate treatment
• Nonunion rates vary: 5-10% overall, higher in specific bones (scaphoid 5-10%, femoral neck 10-30%, tibial shaft 5-15%)
• Risk factors common: Smoking (present in 30-40% of nonunions), diabetes (prevalence increasing), advanced age (population aging)
• Economic impact: Nonunion treatment costs significant healthcare resources, prolonged disability, lost productivity

Primary and Secondary Bone Healing

Primary (Direct) Bone Healing

Definition and Requirements

Primary (direct) bone healing occurs when fracture fragments are anatomically reduced and rigidly fixed with absolute stability, allowing osteoclasts and osteoblasts to cross the fracture directly without intermediate callus formation.

Absolute requirements:

• Anatomical reduction (direct bone-to-bone contact)
• Interfragmentary strain less than 2%
• Compression between fragments (lag screws, compression plates)
• Rigid fixation preventing any motion

Mechanism: Cutting Cones

The cellular mechanism of primary healing is cutting cone (osteon) remodeling:

1. Osteoclast activation: Osteoclasts form at one side of the fracture and begin resorbing bone
2. Cutting cone tunneling: Osteoclasts tunnel across the fracture line in a cone-shaped formation
3. Osteoblast following: Osteoblasts follow behind osteoclasts, depositing new bone (lamellar bone)
4. Haversian system formation: New osteons (Haversian systems) form perpendicular to the fracture, directly bridging the gap
5. Remodeling completion: Multiple cutting cones cross the fracture, restoring continuity

Clinical Examples and Applications

Lag screw fixation:

• Simple oblique or spiral fractures
• Compression across fracture creates absolute stability
• Common in ankle malleoli, forearm bones, scaphoid

Compression plating:

• Dynamic compression plates for forearm, clavicle
• Compression at near cortex, tension at far cortex
• Allows anatomical reduction and rigid fixation

Articular fracture fixation:

• Anatomical reduction essential for joint surface
• Lag screws through plate for compression
• Primary healing restores articular congruity

Advantages and Disadvantages

Advantages:

• Anatomical restoration of bone structure
• Early mechanical stability from implant
• No bulky callus to interfere with soft tissues
• Allows early joint motion (if periarticular fracture)

Disadvantages:

• Requires open reduction and internal fixation (surgical trauma)
• Extensive soft tissue dissection may impair blood supply
• Depends entirely on implant for early strength
• Stress shielding by plate may lead to bone resorption
• Slow biological healing (months for full strength)

Secondary (Indirect) Bone Healing

Definition and Characteristics

Secondary (indirect) bone healing is the natural biological response to fracture when there is relative stability allowing controlled interfragmentary motion. Callus formation bridges the fracture gap through enchondral ossification.

Key features:

• Callus forms around and between fracture fragments
• Healing occurs through four distinct phases
• Enchondral ossification (cartilage intermediate stage)
• Does not require anatomical reduction
• More biologically robust than primary healing

The Four Phases of Secondary Healing

Cellular Biology of Secondary Healing

Clinical Examples of Secondary Healing

Intramedullary nailing:

• Femoral and tibial shaft fractures
• Relative stability allows controlled motion
• Large callus forms, providing biological bridging
• Faster clinical union than plating

External fixation:

• Open fractures, infected nonunions, distraction osteogenesis
• Allows adjustment of stability and compression
• Callus formation monitored and modulated

Cast immobilization:

• Most non-displaced or minimally displaced fractures
• Natural healing pathway
• Callus provides stability as healing progresses

Strain Theory and Mechanical Environment

Perren's Interfragmentary Strain Theory

Strain is defined as the change in fracture gap divided by the original gap: Strain = ΔL / L

Where:

• ΔL = change in gap width with loading
• L = original gap width

Different tissues tolerate different amounts of strain:

Absolute vs Relative Stability

Absolute stability (strain under 2%):

• Achieved by compression across fracture
• Requires anatomical reduction
• Methods: Lag screws, compression plates, external fixators in compression mode
• Result: Primary healing, no callus

Relative stability (strain 2-10%):

• Allows controlled interfragmentary motion
• Does not require anatomical reduction
• Methods: IM nails (locked or unlocked), bridge plating, external fixators with dynamic mode, casts
• Result: Secondary healing with callus

Optimizing Mechanical Environment

Principles for fracture fixation:

1. Match stability to healing goal: Primary healing for articular fractures (need anatomical reduction), secondary healing acceptable for diaphyseal fractures
2. Minimize gap: Large gaps delay or prevent healing. Bone graft if gap over 2-3mm
3. Preserve biology: Minimize periosteal stripping. Indirect reduction techniques when possible
4. Consider dynamization: Can reduce fixation stiffness after initial callus forms to promote remodeling
5. Correct length and alignment: Malreduction impairs healing and function

Diamond Concept of Fracture Healing

The Diamond Concept (Giannoudis et al., 2007) describes four essential elements required for bone healing. Deficiency in any element increases risk of delayed union or nonunion.

The Four Elements

Applying the Diamond Concept

Evaluating nonunion:

• Which element is deficient?
• Cells: Radiation, smoking, excessive stripping?
• Scaffold: Large gap, bone loss?
• Growth factors: Avascular tissue, diabetes?
• Mechanics: Inadequate fixation, persistent motion?

Treatment planning:

• Address all deficient elements
• Example for atrophic nonunion: Provide cells (bone graft), scaffold (graft or plate), growth factors (BMP or DBM), mechanics (stable fixation)
• Example for hypertrophic nonunion: Mechanics likely problem (add compression, reduce gap)

Differential Diagnosis: Impaired Fracture Healing

A fracture that is not progressing must be characterised precisely, because each pattern has a different deficient diamond element and therefore a different treatment. Delayed union and the three nonunion subtypes are the core differential.

Factors Affecting Bone Healing

Patient factors (systemic)

Local factors (fracture-specific)

Medication factors

NSAIDs (Non-Steroidal Anti-Inflammatory Drugs):

• Controversial topic in orthopaedics
• Animal studies show impaired healing (COX-2 important for fracture healing)
• Human studies show mixed results (some show delayed union, others no effect)
• Current consensus: Avoid high-dose long-term NSAIDs (especially COX-2 selective) in high-risk fractures
• Short-term use (under 1-2 weeks) for pain likely acceptable
• Alternative analgesics: Acetaminophen, opioids (short-term), regional anesthesia

Corticosteroids:

• Inhibit osteoblast function and bone formation
• Increase osteoclast activity (bone resorption)
• Suppress inflammatory phase of healing
• Minimize dose and duration if possible
• Consider biological augmentation (BMP) in steroid-dependent patients

Other medications:

• Bisphosphonates: Reduce bone remodeling. May delay remodeling phase but do not prevent healing. Continue for osteoporosis.
• Chemotherapy: Cytotoxic agents impair cell proliferation. Delay elective surgery until after chemotherapy if possible.
• Anticoagulants: Warfarin impairs vitamin K-dependent proteins (osteocalcin). Clinical significance unclear. Continue for thromboembolic disease.

Optimization strategies

Preoperative optimization:

• Smoking cessation (minimum 4 weeks before surgery)
• Glucose control in diabetics (HbA1c under 7%)
• Nutritional supplementation (protein, vitamin D, calcium)
• Minimize steroid dose if possible

Intraoperative techniques:

• Minimize periosteal stripping (preserve blood supply)
• Adequate but not excessive stability
• Fill bone gaps with graft (under 2-3mm can heal, over needs graft)
• Consider biological augmentation in high-risk cases (BMP, bone graft)

Postoperative care:

• Avoid NSAIDs (or use short-term only)
• Early weight-bearing if fixation allows (stimulates healing)
• Monitor healing (clinical exam, radiographs)
• Early intervention if delayed union suspected

Australian Practice Patterns

Fracture management:

• Major trauma centers manage complex fractures and nonunions
• Guidelines from AOA (Australian Orthopaedic Association) inform practice
• Emphasis on evidence-based treatment selection

BMP availability and regulation:

• Recombinant BMP products available but expensive
• PBS (Pharmaceutical Benefits Scheme) does not subsidize BMP
• Use reserved for high-risk cases where benefit justifies cost
• Careful patient selection and informed consent required

Smoking cessation programs:

• Public health campaigns reduce smoking prevalence
• Fracture patients offered smoking cessation support
• Evidence-based counseling improves quit rates

Indigenous health considerations:

• Higher fracture rates in some Indigenous communities
• Diabetes prevalence higher (affects healing)
• Cultural sensitivity in treatment planning
• Attention to compliance and follow-up access

Global Epidemiology of Fractures and Impaired Healing

Fractures are among the most common large-organ traumatic injuries worldwide, and approximately 10% fail to heal normally (Einhorn and Gerstenfeld, Nat Rev Rheumatol 2014, PMID 25266456). Global Burden of Disease modelling shows lower-limb fractures (patella, tibia/fibula, ankle) carry the highest age-standardised prevalence of all fracture sites, with falls the dominant mechanism and a projected continuing rise in fall-related fractures to 2035 (GBD 2019 analysis, PMID 39543488).

Guidance and Principles Across Jurisdictions

Bone-healing biology is governed by AO principles rather than disease-specific guidelines; the table below summarises how the major bodies frame stability and biology, with the underpinning evidence level.

Registry and Surveillance Evidence

There is no dedicated international fracture-healing registry; population-level signal derives from trauma registries and Global Burden of Disease surveillance (PMID 39543488). Where biologics or implants are involved, device and adverse-event surveillance (e.g. national regulator pharmacovigilance) informs practice — for example, post-marketing signals shaped the cautious, lowest-effective-dose use of rhBMP-2/rhBMP-7 in spine and long-bone surgery.

Practice Variation

• Osteobiologic use varies markedly by funding and regulation. rhBMP use is constrained by cost in publicly funded systems; autograft remains the global default for biological augmentation.
• Smoking-cessation pathways differ but the principle (cessation around the time of surgery; structured support) is universal given the OR 2.32 nonunion signal (PMID 24740664).
• NSAID policy varies between centres given dose- and duration-dependent harm in adults but a reassuring profile in children and short courses (PMID 30260913).